Follicular Lesions with Papillary Nuclear Characteristics: Differences in Chromatin Detected by Computerized Image Analysis

Arch Endocrinol Metab. 2021 May 18;64(5):630-635. doi: 10.20945/2359-3997000000282.

Abstract

Objective: Follicular lesions of the thyroid with papillary carcinoma nuclear characteristics are classified as infiltrative follicular variant of papillary thyroid carcinoma-FVPTC (IFVPTC), encapsulated/well demarcated FVPTC with tumour capsular invasion (IEFVPTC), and the newly described category "non-invasive follicular thyroid neoplasm with papillary-like nuclear features" (NIFTP) formerly known as non-invasive encapsulated FVPTC. This study evaluated whether computerized image analysis can detect nuclear differences between these three tumour subtypes.

Methods: Slides with histological material from 15 cases of NIFTP and 33 cases of FVPTC subtypes (22 IEFVPTC, and 11 IFVPTC) were analyzed using the Image J image processing program. Tumour cells were compared for both nuclear morphometry and chromatin textural characteristics.

Results: Nuclei from NIFTP and IFVPTC tumours differed in terms of chromatin textural features (grey intensity): mean (92.37 ± 21.01 vs 72.99 ± 14.73, p = 0.02), median (84.93 ± 21.17 vs 65.18 ± 17.08, p = 0.02), standard deviation (47.77 ± 9.55 vs 39.39 ± 7.18; p = 0.02), and coefficient of variation of standard deviation (19.96 ± 4.01 vs 24.75 ± 3.31; p = 0.003). No differences were found in relation to IEFVPTC.

Conclusion: Computerized image analysis revealed differences in nuclear texture between NIFTP and IFVPTC, but not for IEFVPTC.

Keywords: Carcinoma, Papillary, Follicular; Cell nucleus; Histology; Thyroid neoplasms.

MeSH terms

  • Adenocarcinoma, Follicular* / diagnostic imaging
  • Adenocarcinoma, Follicular* / genetics
  • Carcinoma, Papillary*
  • Carcinoma, Papillary, Follicular*
  • Chromatin
  • Humans
  • Retrospective Studies
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / genetics

Substances

  • Chromatin

Grants and funding

Financial support: the present study was supported by a fellowships supporting from Sao Paulo State University (PROPE-Unesp; process no. 33347) and Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp; process n° 2014/10028-2). Further funding was obtained from FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020 – Operational Program for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT (Fundação para a Ciência e a Tecnologia)/Ministério da Ciência, Tecnologia e Inovação in the framework of the project “Advancing cancer research: from basic knowledgment to application”; NORTE-01-0145-FEDER-000029; “Projetos Estruturados de I&D&I, funded by Norte 2020-Programa Operacional Regional do Norte.